Lantheus Holdings Stock Price and Value Analysis

Lantheus Holdings (NasdaqGM:LNTH) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Lantheus Holdings to reach your target.

Target type

LNTH Free Cash Flow Trend

Free Cash Flow trendline for LNTH
Free Cash Flow trendline for Lantheus Holdings
CSV

Based on historical returns, we believe that Lantheus Holdings can grow its free cash at a rate of about 13%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a great rate!
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the LNTH Numbers

LNTH Price
(Lantheus Holdings stock price per share)
$102.10
[?] LNTH Fair Price
(based on intrinsic value)
$16.66
[?] LNTH Safety Price (based on a variable margin of safety) $10.00
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 25% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Free Cash Flow Jitter 73%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

Recent Insider Activity

Open-market buys and sells reported by Lantheus Holdings's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2024-08-21 Thrall James H Sell 1,000 $98.52
2024-08-14 Niedzwiecki Daniel (See Remarks) Sell 2,500 $97.54
2024-08-12 Ber Gerard Sell 11,175 $96.23
2024-08-12 Ber Gerard Sell 4,225 $97.10
2024-08-12 Ber Gerard Sell 100 $97.78
2024-08-08 Blanchfield Paul (President) Sell 2,000 $96.39
2024-08-02 Heino Mary Anne Sell 3,661 $96.01
2024-08-02 Heino Mary Anne Sell 96 $96.68
2024-08-02 Heino Mary Anne Sell 6,724 $95.20
2024-07-16 Sabens Andrea (Chief Accounting Officer) Sell 1,796 $124.96

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,640,835 shares shorted. With 60,432,214 shares available for purchase and an average trading volume over the past 10 trading days of 1,019,980, it would take at least 3.6 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2013 1521036 -20.6
2014 1521036 5
2015 1521036 13
2016 1521036 41.2
2017 1521036 44.5
2018 1521036 47.9
2019 1521036 64.3
2020 1521036 3
2021 1521036 42
2022 1521036 221
2023 1521036 240
2024 1521036 484
2025 1521036 329

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 7 fiscal years from 2017 to 2025 with positive net income, operating cash flow totaled $1,718 million against net income of $1,096 million, or 1.57 times. Net income was negative in 2 of the 9 years, and those years are left out of the ratio.

In 2025, operating cash flow was 1.67 times net income, compared with 1.00 times for the earliest three years (2017 to 2019).

In 2023, capital expenditures were $45.3 million, 14.9% of operating cash flow of $305 million, which leaves an estimated $260 million after capex. Across the 5 years with reported capex, it averaged 46.6% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2017 123 54.8 17.5 0.44
2018 40.5 61.2 20.1 1.51
2019 31.7 80.4 22.1 2.54
2020 -13.5 16.4 not reported n/a
2021 -71.3 53.9 not reported n/a
2022 28.1 282 260 10.04
2023 327 305 45.3 0.93
2024 312 545 not reported 1.74
2025 234 390 not reported 1.67

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 4 fiscal years from 2013 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $1,014 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 1 of those years with dividend payment facts, dividends paid totaled $0.1 million. No percentage is shown because the estimated free cash flow of those years was not positive in total. Estimated free cash flow was at least the dividends paid in 0 of those 1 years.

In 3 of the 4 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $475 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, cash spent repurchasing shares was $300 million, 91.2% of estimated free cash flow of $329 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2013 -20.6 0.1 0.1 0.2 n/a
2022 221 n/a 75 75 33.9%
2024 484 n/a 100 100 20.7%
2025 329 n/a 300 300 91.2%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $284 million in 2013 and $1,542 million in 2025, a compound annual growth rate of 15.1% over 12 years.

Revenue rose 0.5% from 2024 to 2025.

Our estimated free cash flow was $329 million in 2025, 21.3% of revenue. In 2013 the estimated margin was negative 7.3%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2013 284 -20.6 -7.3%
2014 302 5 1.7%
2015 293 13 4.4%
2016 302 41.2 13.7%
2017 331 44.5 13.4%
2018 343 47.9 14.0%
2019 347 64.3 18.5%
2020 339 3 0.9%
2021 425 42 9.9%
2022 935 221 23.7%
2023 1,296 240 18.5%
2024 1,534 484 31.5%
2025 1,542 329 21.3%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $359 million against total liabilities of $1,138 million, or 31.6% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 51.1% of total assets in 2025, compared with 198.4% in 2014, a decrease of 147.3 percentage points.

Stockholders equity was $1,090 million in 2025, up from negative equity of -$239 million in 2014.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 21.4% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2014 243 19.7 482 -239
2015 242 28.6 428 -185
2016 256 51.2 362 -107
2017 384 76.3 361 23.3
2018 440 113 369 71
2019 406 92.9 291 115
2020 870 79.6 356 514
2021 864 98.5 399 464
2022 1,321 416 874 447
2023 1,651 714 835 816
2024 1,980 913 892 1,088
2025 2,227 359 1,138 1,090

Price Versus Our Estimated Value

Our fair value estimate for Lantheus Holdings is $16.66, below its current price of $102.10.

Of the 13 fiscal years we can see for Lantheus Holdings under its current filer, 12 show positive free cash flow.

Free cash flow is volatile from year to year, with a variability measure of 73%.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

We do not have a dividend yield for Lantheus Holdings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 25% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is in line with the average for stocks in the Diagnostics & Research industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Diagnostics & Research industry, the ones closest in market capitalization to Lantheus Holdings, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Lantheus Holdings (LNTH) 6,677 25.4 - - 513% above
RadNet (RDNT) 5,491 - - 1.4% 42% below
National Research Corporation (NRC) 534 93.2 2.6% - 3712% above
Charles River Laboratories International (CRL) 15,061 341.7 - 2.1% 70% above
Medpace Holdings (MEDP) 17,078 33.9 - - 3621% above
Incyte Corporation (INCY) 23,364 58.5 - 0.6% 166% above
Quest Diagnostics Incorporated (DGX) 28,416 25.7 1.3% 3.0% 25% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1521036.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 1 of the 13 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-21
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: LNTH annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in LNTH

Does Lantheus Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: LNTH

This example shows how we apply the Trendshare checklist to LNTH: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 102.10
    • Market cap: $6.7B
    • EPS: 4.02
  2. Step 2 — Valuation checks

    • P/E: 25.398
    • FCF yield: —
    • Date checked: Nov 21, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.